Results 91 to 100 of about 44,133 (142)

Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer. [PDF]

Can Urol Assoc J, 2013
Chiang AS, Loblaw DA, Jethava V, Sethukavalan P, Zhang L, Vesprini D, Mamedov A, Nam R, Klotz L.   +8 more
europepmc   +1 more source

5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men

, 2020
Cadegiani FA, McCoy J, Wambier CG, Goren A.   +3 more
europepmc   +1 more source

Curcumin versus placebo in benign prostatic hyperplasia: a systematic review and meta-analysis. [PDF]

Eur J Clin Pharmacol
Santana DS, Porto BC, Cardoso RB, Lopes GMM, Gimenez LGS, Passerotti CC, Maia R, Almeida FG, da Silva Sardenberg RA, da Cruz JAS.   +9 more
europepmc   +1 more source

Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study. [PDF]

Eur Urol Open Sci
Ventimiglia E, Westerberg M, Orasson AW, Ahlberg M, Robinson D, Gedeborg R, Stattin P, Garmo H.   +7 more
europepmc   +1 more source

The efficacy of tamsulosin 0.4 mg when tamsulosin 0.2 mg is insufficient for benign prostatic hyperplasia in Korean patients. [PDF]

Investig Clin Urol
Chung Y, Jeong SJ, Song SH, Hong SK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

5-Alpha-Reductase Inhibitors and Combination Therapy

Urologic Clinics of North America, 2016
By inhibiting the conversion from testosterone to dihydrotestosterone 5-Alpha reductase inhibitors (5ARIs) are able to hinder prostatic growth, shrink prostate volumes, and improve BPH-related LUTS. 5ARIs are particularly beneficial for patients with larger prostates (>30-40ml).
Marc Philipp Schneider, Claudius Füllhase   +1 more
exaly   +4 more sources

The risk of dementia with the use of 5 alpha reductase inhibitors

Journal of the Neurological Sciences, 2017
There has been considerable interest in the interplay between testosterone and cognition. Dihydrotestosterone (DHT), which has been correlated with cognitive function, is significantly reduced with the use of 5 alpha reductase inhibitors (5ARI) for prostatic enlargement.
Blayne Welk, Sarah Anne Morrow, Michael Ordon   +2 more
exaly   +3 more sources